Freudenberg Group invests in Cambus Medical
August 17, 2012 - Germany
Helix Medical, a Business Group of the Freudenberg Group and a global manufacturer of components for the medical device industry, is investing in Cambus Medical. Based in Ireland, Cambus Medical manufactures high-precision hypotubes and micro-component solutions for advanced catheter systems. As a first step, Helix Medical will provide a loan to finance the expansion of the operational side of the business. The Freudenberg Business Group will then acquire a 50 percent share of Cambus Medical as of January 2013.
“Cambus complements our product portfolio in another key technology component and represents a further important step in the long-term development of Helix Medical into a global strategic partner for the medical technology industry,” says Dr. Jörg Schneewind, CEO of Helix Medical. The Irish company is a leading designer, developer and manufacturer of high-quality precision components for the medical device industry.
Hypotubes manufactured by Cambus Medical are principally used in catheter systems for diagnostic and therapeutic purposes. Cambus Medical operates a state-of-the-art manufacturing site in Spiddal, near Galway, Ireland. Its manufacturing capabilities range from hypotube coating, to laser precision cutting, EDM and ECM machining, injection molding, laser welding and marking, as well as assembly and packaging of the end product.
Helix Medical already holds a 50 percent share in the Irish manufacturer VistaMed, a leading manufacturer of high-quality, specialty catheters and extruded medical tubing. The new partnership with Cambus Medical extends Helix Medical’s existing portfolio to include components as well as design and manufacturing services for manufacturers of minimally invasive surgical devices.
“With its leading technology and experienced management team, Cambus Medical is in an excellent position to serve the fast growing market for high precision catheter components. Cambus Medical ideally complements the specialty catheter business of our partner, VistaMed,” says Dr. Max Kley, President of Helix Medical Europe. “Helix Medical’s global presence combined with our development and manufacturing capabilities forms an excellent basis for the expansion of our service and product portfolio to our customers worldwide,” adds Barry Comerford, CEO of Cambus Medical.
“Cambus complements our product portfolio in another key technology component and represents a further important step in the long-term development of Helix Medical into a global strategic partner for the medical technology industry,” says Dr. Jörg Schneewind, CEO of Helix Medical. The Irish company is a leading designer, developer and manufacturer of high-quality precision components for the medical device industry.
Hypotubes manufactured by Cambus Medical are principally used in catheter systems for diagnostic and therapeutic purposes. Cambus Medical operates a state-of-the-art manufacturing site in Spiddal, near Galway, Ireland. Its manufacturing capabilities range from hypotube coating, to laser precision cutting, EDM and ECM machining, injection molding, laser welding and marking, as well as assembly and packaging of the end product.
Helix Medical already holds a 50 percent share in the Irish manufacturer VistaMed, a leading manufacturer of high-quality, specialty catheters and extruded medical tubing. The new partnership with Cambus Medical extends Helix Medical’s existing portfolio to include components as well as design and manufacturing services for manufacturers of minimally invasive surgical devices.
“With its leading technology and experienced management team, Cambus Medical is in an excellent position to serve the fast growing market for high precision catheter components. Cambus Medical ideally complements the specialty catheter business of our partner, VistaMed,” says Dr. Max Kley, President of Helix Medical Europe. “Helix Medical’s global presence combined with our development and manufacturing capabilities forms an excellent basis for the expansion of our service and product portfolio to our customers worldwide,” adds Barry Comerford, CEO of Cambus Medical.